With 20 years of experience in the pharmaceutical industry, Clara Campàs Moya understands the healthcare market inside and out. In her view, after decades of impressive progress in medical sciences, it's time for healthcare and pharma companies to become more patient-centric.
Digital technologies can trigger the shift from an antiquated, uncoordinated healthcare infrastructure to one that is based on personalized treatment plans uniquely tailored to an individual's needs.
Gamification for Patients and Return on Investment for Payers
Once you explore the data and available studies, you start believing in how digital therapeutics can transform the quality of care.
Digital therapeutics (DTx) that are clinically validated and comply with regulatory conditions, can have a significant impact on patient well-being and chronic patient therapies. They boost motivation and engagement and can improve measurable indicators like compliance and medication adherence.
“For the patient living with a disease day by day, it’s incredibly demanding to follow various recommendations. Sometimes the treatment depends not only on taking pills but on rethinking their lifestyle. When gamification elements help people make small, healthy decisions and actions, it's already a big win for individuals," according to Clara.
Every patient has their own perception of illness and needs personalized support. Every incentive, guideline, and piece of feedback that shows whether you are staying on track impacts the behavior. DTx harnesses this power, offering a completely new experience.
This modern approach to healthcare employs patient engagement, which is beneficial for patients, payers, health providers, and the healthcare system.
Take, for instance, the patient journey. For the first time, everybody has a chance to follow up on the treatment or prevention outcomes in real-time. By installing an app and logging into the platform, individuals can manage their disease.
The existing transactional model in healthcare must be remodeled. Health insurers, public or private, want to know if what they are paying for brings true value to the patient. This is not surprising – health expenditures are rising rapidly, disproportionately to the outcomes.
Clara claims that present healthcare challenges force the reinvention of reimbursement strategies. DTx can help to capture and monitor the actual effects of the treatment.
“I observe many health insurance companies raising their hands and saying ‘check.’ They want to make the best of the limited amount of money they have. And most importantly, the savings from this value-oriented and rational management of resources go back to the patient.”